U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C5H5NO2
Molecular Weight 111.0987
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 2,3-DIHYDROXYPYRIDINE

SMILES

OC1=CC=CNC1=O

InChI

InChIKey=GGOZGYRTNQBSSA-UHFFFAOYSA-N
InChI=1S/C5H5NO2/c7-4-2-1-3-6-5(4)8/h1-3,7H,(H,6,8)

HIDE SMILES / InChI

Molecular Formula C5H5NO2
Molecular Weight 111.0987
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Pyrimidin-2(1H)-ones based inhibitors of Mycobacterium tuberculosis orotate phosphoribosyltransferase.
2012-08
Recent advances in the treatment of mucormycosis.
2010-11
Synthesis and iron sequestration equilibria of novel exocyclic 3-hydroxy-2-pyridinone donor group siderophore mimics.
2010-09-20
[Fungal diseases of vulva and vagina caused by Candida species].
2010-09
Functional sorbents for selective capture of plutonium, americium, uranium, and thorium in blood.
2010-09
A novel pathway for nicotine degradation by Aspergillus oryzae 112822 isolated from tobacco leaves.
2010-09
The hydroxypyridinone iron chelator CP94 can enhance PpIX-induced PDT of cultured human glioma cells.
2010-06-25
Additive in vitro antiplasmodial effect of N-alkyl and N-benzyl-1,10-phenanthroline derivatives and cysteine protease inhibitor e64.
2010
Antineoplastic Activity of New Transition Metal Complexes of 6-Methylpyridine-2-carbaldehyde-N(4)-ethylthiosemicarbazone: X-Ray Crystal Structures of [VO(2)(mpETSC)] and [Pt(mpETSC)Cl].
2010
Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A.
2009-10-13
A distinct peripheral blood monocyte phenotype is associated with parasite inhibitory activity in acute uncomplicated Plasmodium falciparum malaria.
2009-10
Effects of point mutations in Plasmodium falciparum dihydrofolate reductase and dihydropterate synthase genes on clinical outcomes and in vitro susceptibility to sulfadoxine and pyrimethamine.
2009-08-26
Ethyl 5-[(1H-benzoimidazol-2-yl)amino-carbon-yl]-4-hydr-oxy-2-methyl-6-oxo-1-propyl-1,6-dihydro-pyridine-3-carboxyl-ate-ethanol-methanol (4/2/1).
2009-07-25
Amino-indanol catalyzed enantioselective reactions of 3-hydroxy-2-pyridones.
2009-05-27
Ruthenium-based metallacrown complexes for the selective detection of lithium ions in water and in serum by fluorescence spectroscopy.
2009-03-21
Metal-mediated base pairing within the simplified nucleic acid GNA.
2009-02-07
New tripodal hydroxypyridinone based chelating agents for Fe(III), Al(III) and Ga(III): Synthesis, physico-chemical properties and bioevaluation.
2009-02
Deferiprone glucuronidation by human tissues and recombinant UDP glucuronosyltransferase 1A6: an in vitro investigation of genetic and splice variants.
2009-02
1,2-hydroxypyridonate/terephthalamide complexes of gadolinium(III): synthesis, stability, relaxivity, and water exchange properties.
2009-01-05
Metal-ligand solution equilibria studied by electrospray ionization mass spectrometry: effect of instrumental parameters.
2009-01
Conformational tuning of magnetic interactions in metal-DNA complexes.
2009
Structural origin of copper ion containing artificial DNA: a density functional study.
2008-12-25
Mononuclear metal complexes with ciprofloxacin: Synthesis, characterization and DNA-binding properties.
2008-09
Duplex structure of a minimal nucleic acid.
2008-07-02
Breaking the symmetry: assembly of cylindrical nanostructures with a C3-symmetrical ligand.
2008-06-02
Basic 3-hydroxypyridin-4-ones: potential antimalarial agents.
2008-05
Dioxidobis(2-oxo-1,2-dihydropyridin-3-olato)-molybdenum(VI).
2008-03-29
Terephthalamide-containing ligands: fast removal of iron from transferrin.
2008-02
3-Hydroxypyridin-2-one complexes of near-infrared (NIR) emitting lanthanides: sensitization of holmium(III) and praseodymium(III) in aqueous solution.
2008
Synthesis, Spectroscopic, and Anticancerous Properties of Mixed Ligand Palladium(II) and Silver(I) Complexes with 4,6-Diamino-5-hydroxy-2-mercaptopyrimidine and 2,2'-Bipyridyl.
2008
Deferiprone in the treatment of transfusion-dependent thalassemia: a review and perspective.
2007-10
Direct comparison of delta-aminolevulinic acid and methyl-aminolevulinate-derived protoporphyrin IX accumulations potentiated by desferrioxamine or the novel hydroxypyridinone iron chelator CP94 in cultured human cells.
2007-06-20
Multicomponent assembly of boron-based dendritic nanostructures.
2007-03-16
Metal complexes with the quinolone antibacterial agent N-propyl-norfloxacin: synthesis, structure and bioactivity.
2007-03
FT-IR, FT-Raman spectra and scaled quantum mechanical study of 2,3-dihydroxy pyridine and 2,4-dihyroxy-3-nitropyridine.
2006-11
Novel, efficient total synthesis of natural 20(S)-camptothecin.
2006-10-21
Model complexes of cobalt-substituted matrix metalloproteinases: tools for inhibitor design.
2006-09-04
Bridged dihydroxypyridine ligands for the synthesis of expanded helicates.
2006-08-16
Fe(III)-templated Gd(III) self-assemblies-a new route toward macromolecular MRI contrast agents.
2006-07-26
Iron binding dendrimers: a novel approach for the treatment of haemochromatosis.
2006-07-13
Synthesis and thermodynamic evaluation of mixed hexadentate linear iron chelators containing hydroxypyridinone and terephthalamide units.
2006-05-01
Concise synthesis of 22-hydroxyacuminatine, cytotoxic camptothecinoid from Camptotheca acuminata, by pyridone benzannulation.
2006-02-07
Utilization of self-sorting processes to generate dynamic combinatorial libraries with new network topologies.
2006-01-23
Bifunctional 3-hydroxy-4-pyridinone derivatives as potential pharmaceuticals: synthesis, complexation with Fe(III), Al(III) and Ga(III) and in vivo evaluation with 67Ga.
2005-08
A novel, expeditious synthesis of racemic camptothecin.
2005-07-07
Coordination behavior toward copper(II) and zinc(II) ions of three ligands joining 3-hydroxy-2-pyridinone and polyaza fragments.
2005-05-02
Oxygen accessibility and iron levels are critical factors for the antifungal action of ciclopirox against Candida albicans.
2005-05
Hydroxypyridinone functionalized self-assembled monolayers on nanoporous silica for sequestering lanthanide cations.
2005-04
Study of metal complexes of a tripodal hydroxypyridinone ligand by electrospray tandem mass spectrometry.
2005
Structure-activity relationship of ligands of uracil phosphoribosyltransferase from Toxoplasma gondii.
1994-08-17
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:10:52 GMT 2025
Edited
by admin
on Mon Mar 31 19:10:52 GMT 2025
Record UNII
7HY4BCJ130
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NSC-49272
Preferred Name English
2,3-DIHYDROXYPYRIDINE
Systematic Name English
DIHYDROXYPYRIDINE, 2,3-
Systematic Name English
3-HYDROXY-2-PYRIDONE
Systematic Name English
Code System Code Type Description
EPA CompTox
DTXSID0051782
Created by admin on Mon Mar 31 19:10:52 GMT 2025 , Edited by admin on Mon Mar 31 19:10:52 GMT 2025
PRIMARY
NSC
49272
Created by admin on Mon Mar 31 19:10:52 GMT 2025 , Edited by admin on Mon Mar 31 19:10:52 GMT 2025
PRIMARY
CAS
16867-04-2
Created by admin on Mon Mar 31 19:10:52 GMT 2025 , Edited by admin on Mon Mar 31 19:10:52 GMT 2025
PRIMARY
ECHA (EC/EINECS)
240-887-3
Created by admin on Mon Mar 31 19:10:52 GMT 2025 , Edited by admin on Mon Mar 31 19:10:52 GMT 2025
PRIMARY
MESH
C035877
Created by admin on Mon Mar 31 19:10:52 GMT 2025 , Edited by admin on Mon Mar 31 19:10:52 GMT 2025
PRIMARY
FDA UNII
7HY4BCJ130
Created by admin on Mon Mar 31 19:10:52 GMT 2025 , Edited by admin on Mon Mar 31 19:10:52 GMT 2025
PRIMARY
PUBCHEM
28115
Created by admin on Mon Mar 31 19:10:52 GMT 2025 , Edited by admin on Mon Mar 31 19:10:52 GMT 2025
PRIMARY